Evidence map›Paper›PMID 36979944›Full record

ArticleBiomedicines2023

Effectiveness and Safety of Belimumab in Chinese Lupus Patients: A Multicenter, Real-World Observational Study.

Fangfang Sun, Huaxiang Wu, Zitao Wang, Tong Wu, Xue Wu, Jie Chen, Danting Zhang, Chunde Bao, Nan Shen, Lijun Wu and 2 more

Full text read
PubMed Full text at PMC Publisher
In one paragraph

Article in Biomedicines, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Trial
  2. Article
  3. Observational
  4. Article
  5. [Ovarian function in patients of childbearing age with systemic lupus erythematosus].Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences · 2024
    Article
  6. Article
  7. Observational
  8. Observational
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Fangfang SunDepartment of Rheumatology, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai 201112, China.ORCID 0000-0003-2570-4576
Huaxiang WuDepartment of Rheumatology, The Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou 310009, China.
Zitao WangDepartment of Rheumatology, The Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou 310009, China.
Tong WuDepartment of Rheumatology, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu 610072, China.
Xue WuDepartment of Rheumatology, People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi 830001, China.
Jie ChenDepartment of Rheumatology, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai 201112, China.
Danting ZhangDepartment of Rheumatology, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai 201112, China.
Chunde BaoDepartment of Rheumatology, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai 201112, China.
Nan ShenDepartment of Rheumatology, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai 201112, China.
Lijun WuDepartment of Rheumatology, People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi 830001, China.
Jing ZhuDepartment of Rheumatology, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu 610072, China.
Shuang YeDepartment of Rheumatology, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai 201112, China.

Funding

Modernization of traditional Chinese medicine in Zhejiang Province in 2020 2020ZX008Science and Technology of Sichuan Province 2021YFS0165Shanghai Hospital Development Center SHDC2020CR1015BShanghai Hospital Development Center SHDC2020CR6026Shanghai Municipal Health Commission 202040291
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

disease flareLupus Low Disease Activity State (LLDAS)remissionSLE Responder Index 4 (SRI-4)systemic lupus erythematosus (SLE)

Identifiers

PMID36979944
PMCPMC10046515

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read43
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.